Literature DB >> 603304

Coronary dilatory action of adenosine analogues: a comparative study.

G Raberger, W Schütz, O Kraupp.   

Abstract

The coronary dilatory action of 23 adenosine analogues was investigated on a comparative basis after i.v. administration in anaesthetized dogs. Substitution of adenosine in position 5' with a COOH group and esterification led to a 50- to 100-fold increase in coronary efficacy (flow increase integrated over the time of action). Amidation of the carboxylic acid analogue further enhanced the coronary efficacy. The most effective analogue, adenosine-5'-ethyl-carboxamide, showed 20000 times greater activity than adenosine. Additional substitution in positions 2' and 3' with NO2, O-methoxy-methyliden or O-methoxyethyliden resulted in a delayed onset and prolonged duration of action.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 603304

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  8 in total

1.  Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta.

Authors:  R B Rose'Meyer; W Hope
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

2.  Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells.

Authors:  D Ukena; E Böhme; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

3.  Adenosine A2 receptors on human monocytes modulate C2 production.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

5.  The effect of a long-acting adenosine analog on blood flow through various organs in the dog.

Authors:  W Schütz; O Kraupp; S Bacher; G Raberger
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

6.  Evidence for glucagon-releasing activity of vasoactive adenosine analogues in the conscious dog.

Authors:  W Schütz; G Raberger; O Kraupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

7.  The effects of adenosine-5'-ethylcarboxamide on liver blood flow and hepatic glucose, lactate and pyruvate balances in dogs.

Authors:  G Raberger; T Benke; O Kraupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

8.  Evidence for stereospecificity of the P1-purinoceptor.

Authors:  C Brown; G Burnstock; N J Cusack; P Meghji; C J Moody
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.